Research progress of genes in lung cancer target therapy and clinical molecular pathological detection

doi:10.3969/j.issn.1674-8115.2013.10.001

Abstract

Abstract:

Considerable progress has been made in lung cancer therapy targeted on epidermal growth factor receptor (EGFR) mutation and anaplastic lymphoma kinase (ALK) infusion. The mechanism of genes in lung cancer target therapy, such as EGFR, K-RAS, BRAF, C-MET, EML4-ALK, ROS1 and their relationship with EGFR tyrosine kinase inhibitor (EGFR-TKI) and ALK gene infusion inhibitor are introduced. Meanwhile, important requirements in gene detection are elaborated, including the requirements for specimens, choice of methods and quality control in gene detection of lung cancer.

Key words: lung cancer, target therapy, epidermal growth factor receptor, anaplastic lymphoma kinase, molecular pathology

ZHANG Jie. Research progress of genes in lung cancer target therapy and clinical molecular pathological detection[J]. , doi: 10.3969/j.issn.1674-8115.2013.10.001.

[1]	Yun-fang MA, Li-na PAN, Zhen LI, Bei-li GAO, Jia-an HU, Zhi-hong XU. Exploratory study on downregulation of PD-L1 in KRAS G12V-mutant non-small cell lung cancer cells by selumetinib [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(6): 741-748.
[2]	Jian-hua XU, Ping JIANG, Jiong DENG. Expression and significance of ATP-binding cassette superfamily G member 2 in lung cancer [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(6): 830-833.
[3]	Jia-ling ZHANG, Feng-chun ZHANG, Ying-chun XU. Research progress in the systemic treatment for breast cancer with brain metastasis [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(5): 671-677.
[4]	XU Shu-lin, WU Jing, LOU Jia-tao. Correlation analysis of lung cancer and anemia [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2020, 40(11): 1500-1504.
[5]	HE Chun-ming, YIN Hang, TANG Jian, DING Yi-zong, FU Yu-jie, ZHAO Xiao-jing. Establishment and internal validation of a prognostic model for elderly patients after lung cancer surgery based on SEER [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2020, 40(11): 1554-1561.
[6]	ZHOU Zhen, XU Yun-hua, ZHANG Fei-fei, ZHAO Yi, GUO Lin, FU Guo-long, SHEN Sheng-ping, LENG Xue-jiao. Establishment of a lung cancer momodel with humanized immunity and its role in efficacy evaluation of programmed death-1 inhibitors [J]. , 2020, 40(1): 37-.
[7]	ZOU Chen1, 2, XU Run-hao1, 3, ZHANG Hong2, MA Zhan2, CHEN Li2, ZHANG Jie3, LI Min3, ZHANG Shu-lin1. Potential roles of small metabolites in the differential diagnosis between lung cancer and pneumonia [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2020, 40(08): 1041-1047.
[8]	HE Chun-ming, YIN Hang, ZHENG Jia-jie, TANG Jian, FU Yu-jie, ZHAO Xiao-jing. Immunotherapy for lung cancer: immunosuppressive cells and intrapulmonary immunity [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2020, 40(08): 1137-1142.
[9]	LU Yu-jie, JIN Ze-yu, LI Ya-fen, SHEN Kun-wei, CHEN Wei-guo, CHEN Xiao-song. Receptor status testing and its influence on following treatment selection in breast cancer patients with loco-regional recurrence [J]. , 2019, 39(9): 1071-.
[10]	QU Guo-jun1, LU Yuan-feng2, LI Yu1. Mechanism of CCT2, a new downstream substrate of PDGFRα, on proliferation of tumor cells [J]. , 2019, 39(1): 28-.
[11]	HE Ya-ping1, LOU Wei-qun2, CHEN Jie-ling2, ZHOU Zhen3, ZHU Jing-fen1, JIAN Hong3. Influencing factors for quality of life in patients over 12 months after diagnosis of non-small cell lung cancer [J]. , 2018, 38(7): 775-.
[12]	DAI Wei, WANG Xiao-wen, HUANG Chun, XIANG Xiao-yong, JIANG Yin-jiu, WU Qing-chen. Research progress in the risk factors and mechanisms of postoperative atrial fibrillation after lung cancer surgery [J]. , 2018, 38(5): 573-.
[13]	ZHANG Li-yan, TAN Xiao-ming. Application in diagnosis and treatment of circulating tumor cell detection in lung cancer#br# [J]. , 2018, 38(3): 343-.
[14]	YU Huan1,LI Qing-yun2. Research progress of the local treatments on choroidal metastasis of lung cancer [J]. , 2018, 38(2): 233-.
[15]	WANG Ye, XIE Wang, ZHANG Jie, SHENG Jie-ying, GUO Zhong-liang. Mechanism of hsa-miRNA124-3p regulating the proliferation and migration of human lung cancer cell line NCI-H460#br# [J]. , 2017, 37(8): 1051-.

Research progress of genes in lung cancer target therapy and clinical molecular pathological detection

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

TrendMD

References

Related Articles 15

Recommended Articles

Metrics

Comments